Ubs Group Ag Allovir, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Allovir, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 2,222 shares of ALVR stock, worth $999. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,222

Previous 37,281 94.04%

Holding current value

$999

Previous $26,000 96.15%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $0.82 $24,541 - $28,748	-35,059 Reduced 94.04%	2,222 $1,000
Q2 2024 Aug 13, 2024	SELL	$0.72 - $0.82 $13,114 - $14,936	-18,215 Reduced 32.82%	37,281 $26,000
Q1 2024 May 13, 2024	SELL	$0.64 - $0.78 $3,284 - $4,002	-5,132 Reduced 8.46%	55,496 $42,000
Q4 2023 Feb 09, 2024	BUY	$0.68 - $2.39 $16,572 - $58,249	24,372 Added 67.22%	60,628 $41,000
Q3 2023 Nov 09, 2023	BUY	$2.15 - $3.64 $60,511 - $102,447	28,145 Added 347.0%	36,256 $77,000
Q2 2023 Aug 11, 2023	SELL	$3.17 - $5.82 $25,439 - $46,705	-8,025 Reduced 49.73%	8,111 $27,000
Q1 2023 May 12, 2023	SELL	$3.94 - $7.05 $11,028 - $19,732	-2,799 Reduced 14.78%	16,136 $63,000
Q4 2022 Feb 08, 2023	BUY	$4.7 - $9.98 $85,149 - $180,807	18,117 Added 2214.79%	18,935 $97,000
Q3 2022 Nov 10, 2022	SELL	$4.13 - $8.79 $883 - $1,881	-214 Reduced 20.74%	818 $6,000
Q2 2022 Aug 10, 2022	BUY	$3.26 - $7.06 $9 - $21	3 Added 0.29%	1,032 $4,000
Q1 2022 May 16, 2022	SELL	$6.75 - $13.52 $424,413 - $850,083	-62,876 Reduced 98.39%	1,029 $7,000
Q4 2021 Feb 14, 2022	BUY	$12.94 - $25.99 $257,053 - $516,291	19,865 Added 45.11%	63,905 $827,000
Q3 2021 Nov 15, 2021	BUY	$16.97 - $25.06 $440,405 - $650,357	25,952 Added 143.48%	44,040 $1.1 Million
Q2 2021 Aug 13, 2021	SELL	$19.44 - $25.06 $1.04 Million - $1.35 Million	-53,740 Reduced 74.82%	18,088 $357,000
Q1 2021 May 12, 2021	BUY	$20.81 - $45.5 $1.49 Million - $3.26 Million	71,546 Added 25370.92%	71,828 $1.68 Million
Q4 2020 Feb 11, 2021	SELL	$23.94 - $46.81 $17,356 - $33,937	-725 Reduced 72.0%	282 $11,000
Q3 2020 Nov 12, 2020	BUY	$21.05 - $42.7 $21,197 - $42,998	1,007 New	1,007 $28,000

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $41.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account